{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:36:01Z","timestamp":1793414161731,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR000135"],"award-info":[{"award-number":["UL1 TR000135"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.mayocp.2018.02.010","type":"journal-article","created":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T19:46:09Z","timestamp":1521920769000},"page":"597-606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study"],"prefix":"10.1016","volume":"93","author":[{"given":"Alvise","family":"Berti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S.","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Specks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divi","family":"Cornec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.mayocp.2018.02.010_bib1","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJM199711203372106","article-title":"Small-vessel vasculitis","volume":"337","author":"Jennette","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.mayocp.2018.02.010_bib2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nrrheum.2016.123","article-title":"ANCA-associated vasculitis\u2014 clinical utility of using ANCA specificity to classify patients","volume":"12","author":"Cornec","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.mayocp.2018.02.010_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-111-1-28","article-title":"Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis","volume":"111","author":"N\u00f6lle","year":"1989","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.mayocp.2018.02.010_bib4","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/art.39637","article-title":"Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3","volume":"68","author":"Fussner","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.mayocp.2018.02.010_bib5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-147-9-200711060-00005","article-title":"Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis","volume":"147","author":"Finkielman","year":"2007","journal-title":"Annals Intern Med"},{"issue":"12","key":"10.1016\/j.mayocp.2018.02.010_bib6","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.40313","article-title":"The epidemiology of ANCA associated vasculitis in Olmsted County, Minnesota (USA): a 20 year population-based study","volume":"69","author":"Berti","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.mayocp.2018.02.010_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9343(03)00077-9","article-title":"Use of\u00a0a\u00a0cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse","volume":"114","author":"Langford","year":"2003","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.mayocp.2018.02.010_bib8","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.mayocp.2018.02.010_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mayocp.2018.02.010_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1213277","article-title":"Efficacy of remission-induction regimens for ANCA-associated vasculitis","volume":"369","author":"Specks","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.mayocp.2018.02.010_bib11","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/art.21117","article-title":"Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)","volume":"52","author":"Seo","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.mayocp.2018.02.010_bib12","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1002\/art.39762","article-title":"Risk of myocardial infarction and stroke in patients with granulomatosis with polyangiitis (Wegener's): a population-based study","volume":"68","author":"Avina-Zubieta","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.mayocp.2018.02.010_bib13","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1002\/art.24957","article-title":"Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study","volume":"60","author":"Morgan","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.mayocp.2018.02.010_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.berh.2012.12.004","article-title":"Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides","volume":"27","author":"Cohen Tervaert","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.mayocp.2018.02.010_bib15","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/art.24386","article-title":"Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis","volume":"60","author":"Faurschou","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.mayocp.2018.02.010_bib16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/rheumatology\/ken035","article-title":"Venous thromboembolism in ANCA-associated vasculitis\u2013incidence and risk factors","volume":"47","author":"Stassen","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.mayocp.2018.02.010_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/art.21704","article-title":"Thromboembolic events as a complication of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"55","author":"Weidner","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.mayocp.2018.02.010_bib18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-142-8-200505030-00011","article-title":"Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study","volume":"142","author":"Merkel","year":"2005","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2018.02.010_bib19","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1136\/annrheumdis-2014-206849","article-title":"Venous thromboembolic events in systemic vasculitis","volume":"74","author":"Novikov","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2018.02.010_bib20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/ard.2008.099051","article-title":"High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients","volume":"68","author":"Allenbach","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.mayocp.2018.02.010_bib21","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.3899\/jrheum.130200","article-title":"Patients with antineutrophil cytoplasmic antibodies associated vasculitis in remission are hypercoagulable","volume":"40","author":"Hilhorst","year":"2013","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.mayocp.2018.02.010_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijcard.2015.06.087","article-title":"Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis","volume":"199","author":"Hazebroek","year":"2015","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.mayocp.2018.02.010_bib23","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/aje\/kwq482","article-title":"Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project","volume":"173","author":"St. Sauver","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.mayocp.2018.02.010_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mayocp.2011.11.009","article-title":"Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project","volume":"87","author":"St Sauver","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.mayocp.2018.02.010_bib25","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.mayocp.2012.08.012","article-title":"History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population","volume":"87","author":"Rocca","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.mayocp.2018.02.010_bib26","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.mayocp.2018.02.010_bib27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0197-2456(02)00209-X","article-title":"Design of the Wegener's Granulomatosis Etanercept Trial (WGET)","volume":"23","year":"2002","journal-title":"Control Clin Trials"},{"issue":"8","key":"10.1016\/j.mayocp.2018.02.010_bib28","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.mayocp.2018.02.010_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.mayocp.2018.02.010_bib30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2018.02.010_bib31","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5","article-title":"A\u00a0disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS)","volume":"44","author":"Stone","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.mayocp.2018.02.010_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.CIR.88.1.107","article-title":"Survival after the onset of congestive heart failure in Framingham Heart Study subjects","volume":"88","author":"Ho","year":"1993","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mayocp.2018.02.010_bib33","first-page":"26","article-title":"Peripheral arterial disease: pathophysiology, risk factors, diagnosis, treatment, and prevention","volume":"27","author":"Muir","year":"2009","journal-title":"J\u00a0Vasc Nurs"},{"issue":"10","key":"10.1016\/j.mayocp.2018.02.010_bib34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cpcardiol.2010.08.004","article-title":"Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects","volume":"35","author":"Moxon","year":"2010","journal-title":"Curr Probl Cardiol"},{"issue":"6","key":"10.1016\/j.mayocp.2018.02.010_bib35","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mayocp.2018.02.010_bib36","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.mayocp.2018.02.010_bib37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/rheumatology\/kex338","article-title":"Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies","volume":"57","author":"Houben","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.mayocp.2018.02.010_bib38","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/acr.20433","article-title":"A\u00a0model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis","volume":"63","author":"Suppiah","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2, Suppl 89","key":"10.1016\/j.mayocp.2018.02.010_bib39","article-title":"Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts","volume":"33","author":"Pagnoux","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.mayocp.2018.02.010_bib40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ana.410330103","article-title":"Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic","volume":"33","author":"Nishino","year":"1993","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.mayocp.2018.02.010_bib41","first-page":"2446","article-title":"The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event","volume":"34","author":"Sebastian","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.mayocp.2018.02.010_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1196\/annals.1381.002","article-title":"Atherosclerosis in ANCA-associated vasculitides","volume":"1107","author":"Pagnoux","year":"2007","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"10.1016\/j.mayocp.2018.02.010_bib43","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.20002","article-title":"Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation","volume":"50","author":"Booth","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.mayocp.2018.02.010_bib44","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/jamaneurol.2017.0020","article-title":"Prevalence of cardiovascular risk factors and strokes in younger adults","volume":"74","author":"George","year":"2017","journal-title":"JAMA Neurol"},{"issue":"16","key":"10.1016\/j.mayocp.2018.02.010_bib45","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM199010183231606","article-title":"The value of lowering cholesterol after myocardial infarction","volume":"323","author":"Rossouw","year":"1990","journal-title":"N\u00a0Engl J Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618301095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618301095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T21:22:08Z","timestamp":1534972928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619618301095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0025619618301095"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.02.010","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}